Cargando…
Regulation of Mutant p53 Protein Expression
For several decades, p53 has been detected in cancer biopsies by virtue of its high protein expression level which is considered indicative of mutation. Surprisingly, however, mouse genetic studies revealed that mutant p53 is inherently labile, similar to its wild type (wt) counterpart. Consistently...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681805/ https://www.ncbi.nlm.nih.gov/pubmed/26734569 http://dx.doi.org/10.3389/fonc.2015.00284 |
_version_ | 1782405775048572928 |
---|---|
author | Vijayakumaran, Reshma Tan, Kah Hin Miranda, Panimaya Jeffreena Haupt, Sue Haupt, Ygal |
author_facet | Vijayakumaran, Reshma Tan, Kah Hin Miranda, Panimaya Jeffreena Haupt, Sue Haupt, Ygal |
author_sort | Vijayakumaran, Reshma |
collection | PubMed |
description | For several decades, p53 has been detected in cancer biopsies by virtue of its high protein expression level which is considered indicative of mutation. Surprisingly, however, mouse genetic studies revealed that mutant p53 is inherently labile, similar to its wild type (wt) counterpart. Consistently, in response to stress conditions, both wt and mutant p53 accumulate in cells. While wt p53 returns to basal level following recovery from stress, mutant p53 remains stable. In part, this can be explained in mutant p53-expressing cells by the lack of an auto-regulatory loop with Mdm2 and other negative regulators, which are pivotal for wt p53 regulation. Further, additional protective mechanisms are acquired by mutant p53, largely mediated by the co-chaperones and their paralogs, the stress-induced heat shock proteins. Consequently, mutant p53 is accumulated in cancer cells in response to chronic stress and this accumulation is critical for its oncogenic gain of functions (GOF). Building on the extensive knowledge regarding wt p53, the regulation of mutant p53 is unraveling. In this review, we describe the current understanding on the major levels at which mutant p53 is regulated. These include the regulation of p53 protein levels by microRNA and by enzymes controlling p53 proteasomal degradation. |
format | Online Article Text |
id | pubmed-4681805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-46818052016-01-05 Regulation of Mutant p53 Protein Expression Vijayakumaran, Reshma Tan, Kah Hin Miranda, Panimaya Jeffreena Haupt, Sue Haupt, Ygal Front Oncol Oncology For several decades, p53 has been detected in cancer biopsies by virtue of its high protein expression level which is considered indicative of mutation. Surprisingly, however, mouse genetic studies revealed that mutant p53 is inherently labile, similar to its wild type (wt) counterpart. Consistently, in response to stress conditions, both wt and mutant p53 accumulate in cells. While wt p53 returns to basal level following recovery from stress, mutant p53 remains stable. In part, this can be explained in mutant p53-expressing cells by the lack of an auto-regulatory loop with Mdm2 and other negative regulators, which are pivotal for wt p53 regulation. Further, additional protective mechanisms are acquired by mutant p53, largely mediated by the co-chaperones and their paralogs, the stress-induced heat shock proteins. Consequently, mutant p53 is accumulated in cancer cells in response to chronic stress and this accumulation is critical for its oncogenic gain of functions (GOF). Building on the extensive knowledge regarding wt p53, the regulation of mutant p53 is unraveling. In this review, we describe the current understanding on the major levels at which mutant p53 is regulated. These include the regulation of p53 protein levels by microRNA and by enzymes controlling p53 proteasomal degradation. Frontiers Media S.A. 2015-12-17 /pmc/articles/PMC4681805/ /pubmed/26734569 http://dx.doi.org/10.3389/fonc.2015.00284 Text en Copyright © 2015 Vijayakumaran, Tan, Miranda, Haupt and Haupt. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Vijayakumaran, Reshma Tan, Kah Hin Miranda, Panimaya Jeffreena Haupt, Sue Haupt, Ygal Regulation of Mutant p53 Protein Expression |
title | Regulation of Mutant p53 Protein Expression |
title_full | Regulation of Mutant p53 Protein Expression |
title_fullStr | Regulation of Mutant p53 Protein Expression |
title_full_unstemmed | Regulation of Mutant p53 Protein Expression |
title_short | Regulation of Mutant p53 Protein Expression |
title_sort | regulation of mutant p53 protein expression |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681805/ https://www.ncbi.nlm.nih.gov/pubmed/26734569 http://dx.doi.org/10.3389/fonc.2015.00284 |
work_keys_str_mv | AT vijayakumaranreshma regulationofmutantp53proteinexpression AT tankahhin regulationofmutantp53proteinexpression AT mirandapanimayajeffreena regulationofmutantp53proteinexpression AT hauptsue regulationofmutantp53proteinexpression AT hauptygal regulationofmutantp53proteinexpression |